Two-stage, Randomized, double-blind, placebo-controlled clinical trial on the efficacy and safety of Lagundi (Vitex negundo) tablets/syrup (NIRPROMP formulation) with standard treatment compared to placebo with standard treatment in patients with mild COVID disease without comorbidities
- Funded by Philippine Council for Health Research and Development (PCHRD)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Funder
Philippine Council for Health Research and Development (PCHRD)Principal Investigator
N/A
Research Location
PhilippinesLead Research Institution
N/AResearch Priority Alignment
N/A
Research Category
Clinical characterisation and management
Research Subcategory
Clinical trials for disease management
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Randomized Controlled Trial
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified